Compare ACCL & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACCL | NEPH |
|---|---|---|
| Founded | 2009 | 1997 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8M | 60.0M |
| IPO Year | 2025 | 2004 |
| Metric | ACCL | NEPH |
|---|---|---|
| Price | $3.10 | $5.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 82.0K | 50.3K |
| Earning Date | 02-20-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.91 | N/A |
| EPS | 0.08 | ★ 0.14 |
| Revenue | $4,888,824.00 | ★ $17,930,000.00 |
| Revenue This Year | N/A | $33.32 |
| Revenue Next Year | N/A | $12.27 |
| P/E Ratio | $35.11 | ★ $35.00 |
| Revenue Growth | 11.91 | ★ 32.36 |
| 52 Week Low | $2.10 | $1.39 |
| 52 Week High | $5.00 | $6.42 |
| Indicator | ACCL | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 55.05 |
| Support Level | N/A | $4.74 |
| Resistance Level | N/A | $4.97 |
| Average True Range (ATR) | 0.00 | 0.31 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 84.21 |
Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.